Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in adult Fontan patients: improvement of aerobic capacity
2008-004533-21Phase 4Active
- Sponsor
- Netherlands Heart Institute
- Start
- Nov 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bosentan in Single Ventricle Heart Defects and pulmonary arterial hypertension (PAH), sponsored by Netherlands Heart Institute. Primary endpoint: Change in aerobic capacity. Started Nov 2008; status: active.
02
Drugs
bosentan
03
Conditions
Single Ventricle Heart Defectspulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2008-004533-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004533-21.